USPTO serial 79359922
CUVUE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 5, 2024
- Examiner
- KETCHUM, BRENDAN J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CUVUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of Wilson's disease; pharmaceutical products in the nature of medicines for the treatment of Wilson's disease; chemical preparations for the treatment of Wilson's disease for medical use; chemical preparations for the treatment of Wilson's disease for pharmaceutical use; medicinal substances for the treatment of Wilson's disease; medicinal preparations for the treatment of Wilson's disease; chemical preparations for medical or pharmaceutical use for the treatment of Wilson's disease; pharmaceutical products in the nature of medicines and medicines for the treatment of Wilson's disease; pharmaceutical preparations for the diagnosis of Wilson's disease; pharmaceutical and chemical preparations for measuring copper levels; chemical reagents for medical use, namely, for the diagnosis of Wilson's disease; chemical reagents for diagnostic use in patients suffering from Wilson's disease; pre-filled syringes sold filled with medicine for the treatment of Wilson's disease for medical use; medicated serums for diagnostic use for the diagnosis of Wilson's disease; biological preparations in the nature of medicines for medical use for measuring copper in patients suffering from Wilson's disease; chemical preparations in the nature of medicines for medical use for measuring copper in patients suffering from Wilson's disease; clinical diagnostic reagents; diagnostic preparations in the nature of medicines for medical use for the treatment of Wilson's disease; medical diagnostic reagents and assays for analyzing body fluids to diagnose the level of copper | ACTIVE | — |
| 044 | Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for diagnosing the level of copper in patients suffering from Wilson's disease; medical screening; health care for patients suffering from Wilson's disease; health assessment services for patients suffering from Wilson's disease; home-visit nursing care; blood analysis services provided by medical laboratories for patients suffering from Wilson's disease; medical clinic services and medical analysis services provided by medical laboratories for diagnostic purposes for patients suffering from Wilson's disease; medical analysis services provided by medical laboratories for diagnostic purposes to measure copper levels in patients suffering from Wilson's disease; medical diagnostic testing, monitoring and reporting services for patients suffering from Wilson's disease; medical testing for diagnostic or treatment purposes in the field of Wilson's disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 8, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 9, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 9, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 26, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 25, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 13, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 9, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 6, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |